An In Vivo Study to Determine the Sun Protection Factor - SPF of 4 Sunscreen Formulations. - NIL

Sun Pharmaceutical Industries Limited0 个研究点目标入组 60 人开始时间: 2026年7月14日最近更新: 2026年8月3日

试验速览

暂无简介。

•1 - Healthy adult males and non-pregnant or non-lactating females.
•2 - Participants with ITA value of at least 28 using Chromameter and be untanned on the test area.
•3 - Participants with uniform skin color over the whole test area and with no variation in ITA greater than 5 from each other or the MEDu test area.
•4 - Participants with test sites, free from pigmentation, nevi, sunburn and hair.
•5 - Participants with test sites, free from pigmentation, nevi, sunburn and hair.
•6 - Participants who are free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator.
•7 - Participants who are willing to voluntarily participate in the study and provide signed informed consent.
•8 - Participants who are willing and able to comply with all study requirements and procedures throughout the study duration.

•1 - Participants with a history of abnormal responses to the sun e.g., phototoxic or photoallergic responses.
•2 - Participants with known allergy or sensitivity to cosmetic products and or any ingredients of the test product.
•3 - Participants with systemic dermatological conditions including dysplastic nevi.
•4 - Participants having marks, blemishes or nevi in the test area.
•5 - Participants having excessive hair in the area on the test on the day of testing. Maybe shaved up to 3 days prior to the test day.
•6 - Participants presenting existing sun damage in the test area.
•7 - Participants who have used tanning beds in the previous eight weeks prior to SPF testing.
•8 - Participants who had sun exposure on their back within the eight weeks leading up to the SPF testing.
•9 - Participants using medication with photo-sensitizing potential and or anti-inflammatory medication.
•10 - Participants having skeletal protrusions and extreme areas of curvature in the test area.
•11 - Participants participating in other similar cosmetic or therapeutic study within last eight weeks.
•12 - Any other condition which could warrant exclusion from the study, as per the Dermatologist or investigator discretion.

发起方